Filing Details

Accession Number:
0001104659-17-006179
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-02-02 17:03:59
Reporting Period:
2017-02-01
Filing Date:
2017-02-02
Accepted Time:
2017-02-02 17:03:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1640455 Jounce Therapeutics Inc. JNCE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1260573 A Perry Karsen C/O Jounce Therapeutics, Inc.
1030 Massachusetts Avenue
Cambridge MA 02138
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-02-01 5,000 $16.00 5,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct